Indian Journal of Pharmacology Home 

RESEARCH ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2010  |  Volume : 42  |  Issue : 6  |  Page : 401--405

A comparative study of nebivolol and (S) atenolol on blood pressure and heart rate on essential hypertensive patients

GN Sahana1, N Sarala1, TN Kumar1, V Lakshmaiah2 
1 Department of Pharmacology, Sri Devaraj URS Medical College and R. L. Jalappa Hospital and Research Center, Tamaka Kolar-563 101, India
2 Department of Medicine, Sri Devaraj URS Medical College and R. L. Jalappa Hospital and Research Center, Tamaka Kolar-563 101, India

Correspondence Address:
G N Sahana
Department of Pharmacology, Sri Devaraj URS Medical College and R. L. Jalappa Hospital and Research Center, Tamaka Kolar-563 101
India

Objectives: To study the effect of nebivolol 5 mg once daily versus (S)-atenolol 25 mg once daily in patients with essential hypertension. Materials and Methods: A prospective study was conducted at RLJH and Research Centre which included 30 patients in each group with essential hypertension. The sex, age, presenting illness, and family history of the patients were recorded. Investigations such as blood sugar, urine analysis, kidney function test, lipid profile, and ECG were performed before starting the treatment. Any adverse effects during the treatment were noted. Blood pressure and heart rate were recorded at baseline and during follow-up. One group received nebivolol 5 mg once daily and other group (S)atenolol 25 mg once daily. Patients were followed-up every 15 days for 3 months. Results: Nebivolol group had 18 males and 12 females with mean age 50.6 ± 9.5 years, (S)-atenolol had 16 males and 14 females with mean age 54.4 ± 9 years. Patients receiving nebivolol and (S)-atenolol showed a significant fall (P <·0001) in systolic (SBP), diastolic blood pressure (DBP), and heart rate at the end of first, second, and third month when compared to baseline. The difference in fall in SBP and DBP was insignificant between the groups, but fall in heart rate was significant (P <·0001). Adverse effects such as headache, dizziness, and fatigue were reported with both drugs. Conclusion: Reduction of blood pressure with nebivolol and (S)atenolol was similar, but fall in blood pressure from baseline was highly significant in both groups.


How to cite this article:
Sahana G N, Sarala N, Kumar T N, Lakshmaiah V. A comparative study of nebivolol and (S) atenolol on blood pressure and heart rate on essential hypertensive patients.Indian J Pharmacol 2010;42:401-405


How to cite this URL:
Sahana G N, Sarala N, Kumar T N, Lakshmaiah V. A comparative study of nebivolol and (S) atenolol on blood pressure and heart rate on essential hypertensive patients. Indian J Pharmacol [serial online] 2010 [cited 2020 Oct 29 ];42:401-405
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2010;volume=42;issue=6;spage=401;epage=405;aulast=Sahana;type=0